Skip to main content

Animations

MJFF Publications

5171 - 5180 of 8819 Results
Title
Year
  • Year
  • 2015
  • 2016
  • 2018
  • 2019
  • 2017
  • 2018
  • 2018
  • 2011
  • 2016
  • 2019
  • Summary Details
    OPEN
    Title: A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2015.09.015
    Citation Count: 45
  • Summary Details
    RESTRICTED
    Title: Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s Disease
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-161031
    Citation Count: 14
  • Summary Details
    OPEN
    Title: RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2018.00417
    Citation Count: 43
  • Summary Details
    RESTRICTED
    Title: Effects of Verbal Cueing on Respiratory-Swallow Patterning, Lung Volume Initiation, and Swallow Apnea Duration in Parkinson’s Disease
    Journal Name: Dysphagia
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00455-019-10050-9
    Citation Count: 25
  • Summary Details
    RESTRICTED
    Title: Changes in neuronal activity of cortico‐basal ganglia–thalamic networks induced by acute dopaminergic manipulations in rats
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.13805
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies Treatment
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12611
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-018-1947-3
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.031
    Citation Count: 56
  • Summary Details
    RESTRICTED
    Title: Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats
    Journal Name: Pharmacology Biochemistry and Behavior
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pbb.2016.01.004
    Citation Count: 22
  • Summary Details
    OPEN
    Title: An estimate of the total number of true human miRNAs
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/nar/gkz097
    Citation Count: 494
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.